Cognitive Vitality

A physician says persistent cognitive concerns can warrant baseline testing and follow-up, even when scores remain within the normal range.

• AgeVibrant Team
• October 29, 2026

Observational Alzheimer’s research can reveal patterns and guide further study, but it cannot prove that a behavior or drug prevents dementia.

• AgeVibrant Team
• October 28, 2026

Brain scans link birdwatching expertise with differences in attention and visual-processing networks, but researchers say the findings do not prove it slows decline.

• AgeVibrant Team
• October 27, 2026

A report on posterior cortical atrophy describes how vision-processing problems can delay diagnosis and complicate daily life and care.

• AgeVibrant Team
• October 26, 2026

A Florida Atlantic and Brown study found larger arm movements improved similarity-based pattern learning, but not learning based on explicit rules.

• AgeVibrant Team
• October 26, 2026

In a small, uncontrolled study, breast cancer survivors taking oxaloacetate reported improved cognition after eight weeks. A placebo-controlled trial is planned.

• AgeVibrant Team
• October 24, 2026

A Nature Communications paper describes a 6,217-scan dataset tracking brain imaging, cognition and Alzheimer’s-related biomarkers across aging.

• AgeVibrant Team
• October 23, 2026

The WHO links 45% of dementia risk to 14 modifiable factors, but that does not mean addressing them will prevent 45% of cases.

• AgeVibrant Team
• October 23, 2026

A five-year Duke initiative will fund research and build tools to evaluate and support the safe use of AI in aging and dementia care.

• AgeVibrant Team
• October 22, 2026

A Nature Neuroscience study links Pla2g2f to memory protection in aging mice and reduced lipid buildup in human microglia, but therapy remains unproven.

• AgeVibrant Team
• October 16, 2026